Welcome, Guest |
TOPIC:
Switzerland article 5 years 8 months ago #27076
This is interesting, a journal article about DAA access in Switzerland and how they still need the generic importation mechanism, the tools they have still don't cover everyone. We are similar here in NZ, about to get Mavyret for everyone but it leaves a treatment gap for those with more advanced cirrhosis. This article says, the worlds biggest 'buyers club' is, of course, FixhepC. smw.ch/en/article/doi/smw.2018.14649/ Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716 | |
Switzerland article 5 years 8 months ago #27083
Thanks Hazel. An interesting article that is trying to call it as it is and bring buyer's clubs into the mix as a mainstream option. It really highlights those extraordinary price differences despite some negotiating for lower cost DAAs. G1a probably early 1980's, Biopsy F1(2010), F2-F3(2015). VL 5+mill; 2+mill (2014) Tx naive. Accessed Sof/Led through Dr Freeman at GP2U and Buyers Club (lifesavers!!!) Commenced tx 12/11/15. 9 wk: VL <15 Detected but LFT = Normal 12 week results: UND (Yay!) Due to slow response commenced Sof/Dac 4 Feb for 12 weeks. EOT @ 24 weeks 27 April 2016. (With thanks to Dr Freeman et al). SVR11 result: VL 1,950,000. It's back! New tx 030916 (Viekira Pak, Solvadi, Ribavirin UND @ 111116. EOT 170217. SVR12 and SVR 24 | |
Time to create page: 0.071 seconds